Cytoglobin Silencing Promotes Melanoma Malignancy but Sensitizes for Ferroptosis and Pyroptosis Therapy Response
Despite recent advances in melanoma treatment, there are still patients that either do not respond or develop resistance. This unresponsiveness and/or acquired resistance to therapy could be explained by the fact that some melanoma cells reside in a dedifferentiated state. Interestingly, this dediff...
Saved in:
Main Authors: | Joey De Backer (Author), Darko Maric (Author), Karim Zuhra (Author), Annemie Bogaerts (Author), Csaba Szabo (Author), Wim Vanden Berghe (Author), David Hoogewijs (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Distribution of cytoglobin in the mouse brain
by: Stefan eReuss, et al.
Published: (2016) -
Modulating Nitric Oxide Dioxygenase and Nitrite Reductase of Cytoglobin through Point Mutations
by: John Ukeri, et al.
Published: (2022) -
The Emerging Roles of Pyroptosis, Necroptosis, and Ferroptosis in Non-Malignant Dermatoses: A Review
by: Teng Y, et al.
Published: (2023) -
The role of ferroptosis in the treatment and prognosis of malignant melanoma
by: Yuqing WANG, et al.
Published: (2023) -
Apoptosis, autophagy, ferroptosis, and pyroptosis in cisplatin-induced ototoxicity and protective agents
by: Dingyuan Dai, et al.
Published: (2024)